Trials / Sponsors / Yi-Lun Wang
Yi-Lun Wang
Academic / Other · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Ruxolitinib as add-on Therapy in Steroid-refractory Graft-vs-host Disease Steroid Refractory GVHD | Phase 3 | 2019-01-01 |
Trials / Sponsors / Yi-Lun Wang
Academic / Other · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Ruxolitinib as add-on Therapy in Steroid-refractory Graft-vs-host Disease Steroid Refractory GVHD | Phase 3 | 2019-01-01 |